MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Begleiter, A.
Right arrow Articles by Leith, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Begleiter, A.
Right arrow Articles by Leith, M. K.

Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions

A Begleiter and MK Leith

Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada.

The quinone antitumor agent mitomycin C is preferentially toxic to some cells under hypoxic and acidic conditions. The two-electron reducing enzyme DT-diaphorase may be a major contributor to mitomycin C activation under aerobic conditions, but its role in drug activation under hypoxic and acidic conditions is unclear. In this study, we observed that mitomycin C produced increased DNA cross-linking and cytotoxicity in Chinese hamster ovary cells at pH 6.6, compared with pH 7.2, under aerobic conditions, but drug activity was similar at these pH values under hypoxic conditions. The DT-diaphorase inhibitor dicoumarol completely inhibited the enhanced activity of mitomycin C at acidic pH under aerobic conditions but had no effect on DNA cross- linking or cytotoxicity under hypoxic conditions. These finding suggest that the enhanced activity of mitomycin C at acidic pH, in air, is due to increased drug activation by DT-diaphorase. However, the role of DT- diaphorase in activating mitomycin C under hypoxic conditions appears to be limited, even at acidic pH.

Volume 44, Issue 1, pp. 210-215, 07/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
R. L. Cowen, A. V. Patterson, B. A. Telfer, R. E. Airley, S. Hobbs, R. M. Phillips, M. Jaffar, I. J. Stratford, and K. J. Williams
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts
Mol. Cancer Ther., September 1, 2003; 2(9): 901 - 909.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
F. Zappa, T. Ward, E. Pedrinis, J. Butler, and A. McGown
NAD(P)H:Quinone Oxidoreductase 1 Expression in Kidney Podocytes
J. Histochem. Cytochem., March 1, 2003; 51(3): 297 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. M. Prescott, H. C. Charles, J. M. Poulson, R. L. Page, D. E. Thrall, Z. Vujaskovic, and M. W. Dewhirst
The Relationship between Intracellular and Extracellular pH in Spontaneous Canine Tumors
Clin. Cancer Res., June 1, 2000; 6(6): 2501 - 2505.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics